Evidence map›Paper›PMID 40584340›Full record

ArticleACS omega2025

Molecular Design Considerations for Azobenzene Anolytes.

Ananya Banik, Uddalak Sengupta, Haley Hughes, Palani Sabhapathy, Burcu Gurkan, Emily B Pentzer, David C Powers

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ananya BanikTexas A&M University, Department of Chemistry, College Station, Texas 77843, United States.
Uddalak SenguptaTexas A&M University, Department of Chemistry, College Station, Texas 77843, United States.
Haley HughesTexas A&M University, Department of Chemistry, College Station, Texas 77843, United States.
Palani SabhapathyCase Western Reserve University, Department of Chemical and Biomolecular Engineering, Cleveland, Ohio 44106, United States.
Burcu GurkanCase Western Reserve University, Department of Chemical and Biomolecular Engineering, Cleveland, Ohio 44106, United States.ORCID https://orcid.org/0000-0003-4886-3350
Emily B PentzerTexas A&M University, Department of Chemistry, College Station, Texas 77843, United States.ORCID https://orcid.org/0000-0001-6187-6135
David C PowersTexas A&M University, Department of Chemistry, College Station, Texas 77843, United States.ORCID https://orcid.org/0000-0003-3717-2001

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Realization of high-density batteries requires the development of anolytes that display highly negative reduction potentials, solubility, and persistence in the charged state. Azobenzenes have garnered interest as potential anolytes for redox flow batteries. Here, we report the synthesis of a family of substituted azobenzene derivatives and evaluation of their solution-phase electrochemical properties. Systematic synthetic derivatization of this scaffold allows (1) access to anolytes of varying solubility, including intrinsically liquid derivatives that represent potential high-density charge carriers; (2) systematic variation of the reduction potential, and in some cases redox inventory, that provides azobenzenes with highly negative reduction potentials; and (3) control of the lifetime of the azobenzene radical anions that result from one-electron reduction. Electrokinetic experiments demonstrated that fast electron transfer occurs for all derivatives examined. Spectroscopic characterization of monoreduced azobenzene derivatives establishes that decomposition of the azobenzene radical anion proceeds via bimolecular disproportionation. Together, these results provide an experimental basis for the optimization of azobenzene anolytes for electrochemical storage applications, including redox flow batteries.

Identifiers

PMID40584340
PMCPMC12199068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.